EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients

Jun-Tao Tan iD, Lili Hu, Qi-Hua Jiang, Hai Hu, Zhi Yang, Zhi-Hua Li, Ping-Hua Hu iD

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251342877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Jun-Tao Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China. Hauptthemen laut MEDLINE: Breast Neoplasms, B7-H1 Antigen, Calcitonin Gene-Related Peptide, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Peripherally inserted central catheter (PICC)-related bloodstream infections (BSIs) are severe complications in breast cancer patients undergoing chemotherapy. This study evaluated the diagnostic potential of calcitonin gene-related peptide (CGRP), programmed cell death protein-1 (PD-1), and its ligand (PD-L1) as biomarkers for PICC-related BSIs.

Methods

A total of 384 breast cancer patients with PICC placement were retrospectively identified from medical records, of these, 78 developed BSIs and 306 did not. Serum levels of CGRP, PD-1, and PD-L1 were measured using enzyme-linked immunosorbent assay (ELISA) and quantitative polymerase chain reaction (qPCR), respectively, to evaluate their potential as diagnostic biomarkers for BSIs. Blood cultures were performed to confirm infections and identify pathogens.

Results

The BSIs group showed significantly lower CGRP and PD-L1 levels, and higher PD-1 expression and PD-1/PD-L1 ratios compared to the non-BSIs group (all P < 0.001). Receiver operating characteristic (ROC) curve analysis showed area under the curve (AUC) values of 0.84 for CGRP, 0.77 for PD-1, 0.70 for PD-L1, and 0.86 for the PD-1/PD-L1 ratio. Combined detection achieved an AUC of 0.96, with 88% sensitivity and 92% specificity. Gram-negative bacteria (59.8%) were the predominant pathogens, with Escherichia coli (29.3%) being the most common.

Conclusion

CGRP alone showed strong diagnostic utility, but combining CGRP, PD-1, and PD-L1 markedly enhanced accuracy. ELISA and qPCR detection of these markers provides results within hours, enabling earlier diagnosis than conventional blood cultures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsB7-H1 AntigenCalcitonin Gene-Related PeptideProgrammed Cell Death 1 ReceptorCatheter-Related InfectionsHumansFemaleMiddle AgedROC CurveAgedBiomarkersRetrospective StudiesAdultBiomarkers, Tumor

Stichwörter der Autor:innen

biomarkersbreast cancercalcitonin gene-related peptideperipherally inserted central catheter-related bloodstream infectionsprogrammed cell death protein-1programmed death-ligand 1

Substanzen

B7-H1 AntigenCalcitonin Gene-Related PeptideProgrammed Cell Death 1 ReceptorCD274 protein, humanBiomarkersPDCD1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China.
  • Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital, Nanchang, China.
  • Department of pediatrics, Nanchang People's Hospital, Nanchang, China.
  • Department of General Surgery, Nanchang People's Hospital, Nanchang, China.
  • Department of Endocrinology and Metabolism, Nanchang People's Hospital, Nanchang, China.

ORCID-Profile: Jun-Tao Tan, Ping-Hua Hu

Zitieren

APA

Tan, J. T., Hu, L., Jiang, Q. H., Hu, H., Yang, Z., Li, Z. H., & Hu, P. H. (2025). CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251342877

Vancouver

Tan JT, Hu L, Jiang QH, Hu H, Yang Z, Li ZH, et al. CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251342877

BibTeX
@article{Tan2025,
  author = {Tan, Jun-Tao and Hu, Lili and Jiang, Qi-Hua and Hu, Hai and Yang, Zhi and Li, Zhi-Hua and Hu, Ping-Hua},
  title = {CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251342877}
}
Kostenlos starten →